Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 114 entries
Sorted by: Best Match Show Resources per page
Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures.

Translational gastroenterology and hepatology

Uchiyama H, Shirabe K, Araki K, Sugimachi K, Morita K, Takenaka K, Maehara Y.
PMID: 28529988
Transl Gastroenterol Hepatol. 2017 Apr 28;2:34. doi: 10.21037/tgh.2017.03.16. eCollection 2017.

Hepatectomy needing simultaneous reconstruction of the hepatic artery and the portal vein in the operation for cholangiocarcinoma is a challenging procedure. We experienced three cases of left hepatectomy with simultaneous reconstructions of the right hepatic artery (RHA) and the...

Cite
Uchiyama H, Shirabe K, Araki K, et al. Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures. Transl Gastroenterol Hepatol. 2017;2:34doi: 10.21037/tgh.2017.03.16.
Uchiyama, H., Shirabe, K., Araki, K., Sugimachi, K., Morita, K., Takenaka, K., & Maehara, Y. (2017). Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures. Translational gastroenterology and hepatology, 234. https://doi.org/10.21037/tgh.2017.03.16
Uchiyama, Hideaki, et al. "Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures." Translational gastroenterology and hepatology vol. 2 (2017): 34. doi: https://doi.org/10.21037/tgh.2017.03.16
Uchiyama H, Shirabe K, Araki K, Sugimachi K, Morita K, Takenaka K, Maehara Y. Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures. Transl Gastroenterol Hepatol. 2017 Apr 28;2:34. doi: 10.21037/tgh.2017.03.16. eCollection 2017. PMID: 28529988; PMCID: PMC5420523.
Copy Download .nbib Format: NLM
The author replies.

Surgical endoscopy

Shimada M, Hashizume M, Sugimachi K.
PMID: 11178776
Surg Endosc. 2001 Jan;15(1):105. doi: 10.1007/s004640000278.

No abstract available.

Cite
Shimada M, Hashizume M, Sugimachi K. The author replies. Surg Endosc. 2001;15(1):105doi: 10.1007/s004640000278.
Shimada, M., Hashizume, M., & Sugimachi, K. (2001). The author replies. Surgical endoscopy, 15(1), 105. https://doi.org/10.1007/s004640000278
Shimada, M, et al. "The author replies." Surgical endoscopy vol. 15,1 (2001): 105. doi: https://doi.org/10.1007/s004640000278
Shimada M, Hashizume M, Sugimachi K. The author replies. Surg Endosc. 2001 Jan;15(1):105. doi: 10.1007/s004640000278. PMID: 11178776.
Copy Download .nbib Format: NLM
Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions.

Cytotechnology

Nakazawa K, Mizumoto H, Kaneko M, Ijima H, Gion T, Shimada M, Shirabe K, Takenaka K, Sugimachi K, Funatsu K.
PMID: 19003125
Cytotechnology. 1999 Sep;31(1):61-8. doi: 10.1023/A:1008040726236.

Porcine hepatocytes are used in the hybrid artificial liver support system that we are developing because of their high level of liver functions in vitro and because human hepatocytes can not be used in Japan for ethical reasons. Spherical...

Cite
Nakazawa K, Mizumoto H, Kaneko M, et al. Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions. Cytotechnology. 1999;31(1):61-8doi: 10.1023/A:1008040726236.
Nakazawa, K., Mizumoto, H., Kaneko, M., Ijima, H., Gion, T., Shimada, M., Shirabe, K., Takenaka, K., Sugimachi, K., & Funatsu, K. (1999). Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions. Cytotechnology, 31(1), 61-8. https://doi.org/10.1023/A:1008040726236
Nakazawa, K, et al. "Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions." Cytotechnology vol. 31,1 (1999): 61-8. doi: https://doi.org/10.1023/A:1008040726236
Nakazawa K, Mizumoto H, Kaneko M, Ijima H, Gion T, Shimada M, Shirabe K, Takenaka K, Sugimachi K, Funatsu K. Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions. Cytotechnology. 1999 Sep;31(1):61-8. doi: 10.1023/A:1008040726236. PMID: 19003125; PMCID: PMC3449777.
Copy Download .nbib Format: NLM
Significance of alpha-1-antitrypsin mRNA expression in esophageal carcinoma.

International journal of oncology

Mimori K, Mori M, Mafune K, Tanaka Y, Li J, Fukumaki Y, Matsuda M, Sugimachi K, Akiyoshi T.
PMID: 21541594
Int J Oncol. 1996 Nov;9(5):907-10. doi: 10.3892/ijo.9.5.907.

Alpha-1-antitrypsin (alpha 1AT) is present not only in the normal gastrointestine, but in malignant gastrointestinal tissue as well. We studied the expression of alpha 1AT mRNA in 30 cases of esophageal carcinoma using a Northern blot analysis. In addition,...

Cite
Mimori K, Mori M, Mafune K, et al. Significance of alpha-1-antitrypsin mRNA expression in esophageal carcinoma. Int J Oncol. 1996;9(5):907-10doi: 10.3892/ijo.9.5.907.
Mimori, K., Mori, M., Mafune, K., Tanaka, Y., Li, J., Fukumaki, Y., Matsuda, M., Sugimachi, K., & Akiyoshi, T. (1996). Significance of alpha-1-antitrypsin mRNA expression in esophageal carcinoma. International journal of oncology, 9(5), 907-10. https://doi.org/10.3892/ijo.9.5.907
Mimori, K, et al. "Significance of alpha-1-antitrypsin mRNA expression in esophageal carcinoma." International journal of oncology vol. 9,5 (1996): 907-10. doi: https://doi.org/10.3892/ijo.9.5.907
Mimori K, Mori M, Mafune K, Tanaka Y, Li J, Fukumaki Y, Matsuda M, Sugimachi K, Akiyoshi T. Significance of alpha-1-antitrypsin mRNA expression in esophageal carcinoma. Int J Oncol. 1996 Nov;9(5):907-10. doi: 10.3892/ijo.9.5.907. PMID: 21541594.
Copy Download .nbib Format: NLM
Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas.

International journal of oncology

Toh Y, Kuwano H, Sonoda K, Saeki H, Kawaguchi H, Kitamura K, Nakashima H, Sugimachi K.
PMID: 21528264
Int J Oncol. 1997 Oct;11(4):703-8. doi: 10.3892/ijo.11.4.703.

p21(WAF1/CIP1) is a potent inhibitor of various cyclin-dependent kinases, the expression of which is transcriptionally regulated by tumor suppressor gene product p53. We immunohistochemically examined the expression of p53 and p21(WAF1/CIP1) in 61 esophageal squamous cell carcinomas. p53 protein...

Cite
Toh Y, Kuwano H, Sonoda K, et al. Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas. Int J Oncol. 1997;11(4):703-8doi: 10.3892/ijo.11.4.703.
Toh, Y., Kuwano, H., Sonoda, K., Saeki, H., Kawaguchi, H., Kitamura, K., Nakashima, H., & Sugimachi, K. (1997). Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas. International journal of oncology, 11(4), 703-8. https://doi.org/10.3892/ijo.11.4.703
Toh, Y, et al. "Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas." International journal of oncology vol. 11,4 (1997): 703-8. doi: https://doi.org/10.3892/ijo.11.4.703
Toh Y, Kuwano H, Sonoda K, Saeki H, Kawaguchi H, Kitamura K, Nakashima H, Sugimachi K. Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas. Int J Oncol. 1997 Oct;11(4):703-8. doi: 10.3892/ijo.11.4.703. PMID: 21528264.
Copy Download .nbib Format: NLM
Sensitivity of hepatocellular carcinoma to nine anticancer drugs is unchanged after administration of epirubicin suspended in lipiodol.

International journal of oncology

Nishizaki T, Takenaka K, Yanaga K, Kishikawa K, Maehara Y, Shimada M, Sugimachi K.
PMID: 21544464
Int J Oncol. 1996 Jun;8(6):1059-62. doi: 10.3892/ijo.8.6.1059.

Multidrug resistance is a major obstacle to the successful chemotherapy for human cancers. The chemosensitivities of hepatocellular carcinoma (HCC) treated with preoperative lipiodolization (LPD) to anticancer agents were compared to those without chemotherapy. Data on 22 patients with HCC...

Cite
Nishizaki T, Takenaka K, Yanaga K, et al. Sensitivity of hepatocellular carcinoma to nine anticancer drugs is unchanged after administration of epirubicin suspended in lipiodol. Int J Oncol. 1996;8(6):1059-62doi: 10.3892/ijo.8.6.1059.
Nishizaki, T., Takenaka, K., Yanaga, K., Kishikawa, K., Maehara, Y., Shimada, M., & Sugimachi, K. (1996). Sensitivity of hepatocellular carcinoma to nine anticancer drugs is unchanged after administration of epirubicin suspended in lipiodol. International journal of oncology, 8(6), 1059-62. https://doi.org/10.3892/ijo.8.6.1059
Nishizaki, T, et al. "Sensitivity of hepatocellular carcinoma to nine anticancer drugs is unchanged after administration of epirubicin suspended in lipiodol." International journal of oncology vol. 8,6 (1996): 1059-62. doi: https://doi.org/10.3892/ijo.8.6.1059
Nishizaki T, Takenaka K, Yanaga K, Kishikawa K, Maehara Y, Shimada M, Sugimachi K. Sensitivity of hepatocellular carcinoma to nine anticancer drugs is unchanged after administration of epirubicin suspended in lipiodol. Int J Oncol. 1996 Jun;8(6):1059-62. doi: 10.3892/ijo.8.6.1059. PMID: 21544464.
Copy Download .nbib Format: NLM
Combination chemotherapy with methotrexate and 5-Fluorouracil and surgery for advanced gastric-cancer with liver and lymph-node metastases - a case-report.

Oncology reports

Korenaga D, Takesue F, Toh Y, Maekawa S, Ikeda T, Sugimachi K.
PMID: 21597765
Oncol Rep. 1995 Jul;2(4):505-7. doi: 10.3892/or.2.4.505.

We report on a case of advanced gastric cancer with multiple liver metastasis and lymph node metastases in a 65-year-old Japanese man. He was treated with sequential intravenous administration of moderate-dose methotrexate 1 (MTX) and 5-fluorouracil (5-FU) preoperatively. After...

Cite
Korenaga D, Takesue F, Toh Y, et al. Combination chemotherapy with methotrexate and 5-Fluorouracil and surgery for advanced gastric-cancer with liver and lymph-node metastases - a case-report. Oncol Rep. 1995;2(4):505-7doi: 10.3892/or.2.4.505.
Korenaga, D., Takesue, F., Toh, Y., Maekawa, S., Ikeda, T., & Sugimachi, K. (1995). Combination chemotherapy with methotrexate and 5-Fluorouracil and surgery for advanced gastric-cancer with liver and lymph-node metastases - a case-report. Oncology reports, 2(4), 505-7. https://doi.org/10.3892/or.2.4.505
Korenaga, D, et al. "Combination chemotherapy with methotrexate and 5-Fluorouracil and surgery for advanced gastric-cancer with liver and lymph-node metastases - a case-report." Oncology reports vol. 2,4 (1995): 505-7. doi: https://doi.org/10.3892/or.2.4.505
Korenaga D, Takesue F, Toh Y, Maekawa S, Ikeda T, Sugimachi K. Combination chemotherapy with methotrexate and 5-Fluorouracil and surgery for advanced gastric-cancer with liver and lymph-node metastases - a case-report. Oncol Rep. 1995 Jul;2(4):505-7. doi: 10.3892/or.2.4.505. PMID: 21597765.
Copy Download .nbib Format: NLM
Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer.

Oncology letters

Mima K, Fukagawa T, Kurashige J, Takano Y, Uchi R, Ueo H, Matsumura T, Ishibashi M, Sawada G, Takahashi Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Watanabe M, Ishii H, Mori M, Baba H, Sasako M, Mimori K.
PMID: 24137334
Oncol Lett. 2013 Aug;6(2):387-392. doi: 10.3892/ol.2013.1392. Epub 2013 Jun 12.

The prognosis for individuals that are diagnosed with gastric cancer remains poor due to the high frequency of metastatic disease. In response to tumor-derived secreted factors, the bone marrow generates a suitable microenvironment for the development of metastasis. However,...

Cite
Mima K, Fukagawa T, Kurashige J, et al. Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer. Oncol Lett. 2013;6(2):387-392doi: 10.3892/ol.2013.1392.
Mima, K., Fukagawa, T., Kurashige, J., Takano, Y., Uchi, R., Ueo, H., Matsumura, T., Ishibashi, M., Sawada, G., Takahashi, Y., Akiyoshi, S., Eguchi, H., Sudo, T., Sugimachi, K., Watanabe, M., Ishii, H., Mori, M., Baba, H., Sasako, M., & Mimori, K. (2013). Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer. Oncology letters, 6(2), 387-392. https://doi.org/10.3892/ol.2013.1392
Mima, Kosuke, et al. "Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer." Oncology letters vol. 6,2 (2013): 387-392. doi: https://doi.org/10.3892/ol.2013.1392
Mima K, Fukagawa T, Kurashige J, Takano Y, Uchi R, Ueo H, Matsumura T, Ishibashi M, Sawada G, Takahashi Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Watanabe M, Ishii H, Mori M, Baba H, Sasako M, Mimori K. Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer. Oncol Lett. 2013 Aug;6(2):387-392. doi: 10.3892/ol.2013.1392. Epub 2013 Jun 12. PMID: 24137334; PMCID: PMC3788827.
Copy Download .nbib Format: NLM
Indications for performing transanal endoscopic microsurgery (TEM) in rectal cancer patients.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Ikeda, Mori, Abe, Koyanagi, Akahoshi, Sugimachi.
PMID: 23577928
Colorectal Dis. 2000 Jan;2(1):13-7. doi: 10.1046/j.1463-1318.2000.00131.x.

OBJECTIVE: The aim of this study was to clarify the application of a local excision using TEM for rectal cancer.PATIENTS AND METHODS: Fifteen patients were preoperatively diagnosed to have cancer invasion in the submucosa (T1) and thus were treated...

Cite
Ikeda, Mori, Abe, et al. Indications for performing transanal endoscopic microsurgery (TEM) in rectal cancer patients. Colorectal Dis. 2000;2(1):13-7doi: 10.1046/j.1463-1318.2000.00131.x.
Ikeda, Mori, Abe, Koyanagi, Akahoshi, & Sugimachi. (2000). Indications for performing transanal endoscopic microsurgery (TEM) in rectal cancer patients. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2(1), 13-7. https://doi.org/10.1046/j.1463-1318.2000.00131.x
Ikeda, et al. "Indications for performing transanal endoscopic microsurgery (TEM) in rectal cancer patients." Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland vol. 2,1 (2000): 13-7. doi: https://doi.org/10.1046/j.1463-1318.2000.00131.x
Ikeda, Mori, Abe, Koyanagi, Akahoshi, Sugimachi. Indications for performing transanal endoscopic microsurgery (TEM) in rectal cancer patients. Colorectal Dis. 2000 Jan;2(1):13-7. doi: 10.1046/j.1463-1318.2000.00131.x. PMID: 23577928.
Copy Download .nbib Format: NLM
Clinical significance of .

Oncology letters

Nambara S, Masuda T, Tobo T, Kidogami S, Komatsu H, Sugimachi K, Saeki H, Oki E, Maehara Y, Mimori K.
PMID: 28789412
Oncol Lett. 2017 Aug;14(2):1795-1801. doi: 10.3892/ol.2017.6341. Epub 2017 Jun 08.

The present authors previously identified a novel candidate tumor suppressor gene, zinc finger protein 750 (

Cite
Nambara S, Masuda T, Tobo T, et al. Clinical significance of . Oncol Lett. 2017;14(2):1795-1801doi: 10.3892/ol.2017.6341.
Nambara, S., Masuda, T., Tobo, T., Kidogami, S., Komatsu, H., Sugimachi, K., Saeki, H., Oki, E., Maehara, Y., & Mimori, K. (2017). Clinical significance of . Oncology letters, 14(2), 1795-1801. https://doi.org/10.3892/ol.2017.6341
Nambara, Sho, et al. "Clinical significance of ." Oncology letters vol. 14,2 (2017): 1795-1801. doi: https://doi.org/10.3892/ol.2017.6341
Nambara S, Masuda T, Tobo T, Kidogami S, Komatsu H, Sugimachi K, Saeki H, Oki E, Maehara Y, Mimori K. Clinical significance of . Oncol Lett. 2017 Aug;14(2):1795-1801. doi: 10.3892/ol.2017.6341. Epub 2017 Jun 08. PMID: 28789412; PMCID: PMC5529940.
Copy Download .nbib Format: NLM
Synergism of cytotoxicity between cis-diaminedichloro-platinum-(ii) and cis-diamine(1,1-cyclobutanedicarboxylate)-platinum-(ii).

International journal of oncology

Baba H, Maehara Y, Takeuchi H, Inutsuka S, Yamamoto M, Endo K, Sugimachi K.
PMID: 21566928
Int J Oncol. 1994 Feb;4(2):329-33.

In an attempts to increase the antitumor effect and to reduce normal tissue toxicity, the combined cytotoxic effect of cis-Diamminedichloroplatinum (II) (CDDP) and cis-diammine(1,1-cyclobutane dicarboxylate) platinum (II) (CBDCA) was investigated using HeLa and colon 26 cell lines and the...

Cite
Baba H, Maehara Y, Takeuchi H, et al. Synergism of cytotoxicity between cis-diaminedichloro-platinum-(ii) and cis-diamine(1,1-cyclobutanedicarboxylate)-platinum-(ii). Int J Oncol. 1994;4(2):329-33
Baba, H., Maehara, Y., Takeuchi, H., Inutsuka, S., Yamamoto, M., Endo, K., & Sugimachi, K. (1994). Synergism of cytotoxicity between cis-diaminedichloro-platinum-(ii) and cis-diamine(1,1-cyclobutanedicarboxylate)-platinum-(ii). International journal of oncology, 4(2), 329-33.
Baba, H, et al. "Synergism of cytotoxicity between cis-diaminedichloro-platinum-(ii) and cis-diamine(1,1-cyclobutanedicarboxylate)-platinum-(ii)." International journal of oncology vol. 4,2 (1994): 329-33.
Baba H, Maehara Y, Takeuchi H, Inutsuka S, Yamamoto M, Endo K, Sugimachi K. Synergism of cytotoxicity between cis-diaminedichloro-platinum-(ii) and cis-diamine(1,1-cyclobutanedicarboxylate)-platinum-(ii). Int J Oncol. 1994 Feb;4(2):329-33. PMID: 21566928.
Copy Download .nbib Format: NLM
Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.

PLoS genetics

Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.
PMID: 28542232
PLoS Genet. 2017 May 19;13(5):e1006798. doi: 10.1371/journal.pgen.1006798. eCollection 2017 May.

[This corrects the article DOI: 10.1371/journal.pgen.1005778.].

Cite
Uchi R, Takahashi Y, Niida A, et al. Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution. PLoS Genet. 2017;13(5):e1006798doi: 10.1371/journal.pgen.1006798.
Uchi, R., Takahashi, Y., Niida, A., Shimamura, T., Hirata, H., Sugimachi, K., Sawada, G., Iwaya, T., Kurashige, J., Shinden, Y., Iguchi, T., Eguchi, H., Chiba, K., Shiraishi, Y., Nagae, G., Yoshida, K., Nagata, Y., Haeno, H., Yamamoto, H., Ishii, H., Doki, Y., Iinuma, H., Sasaki, S., Nagayama, S., Yamada, K., Yachida, S., Kato, M., Shibata, T., Oki, E., Saeki, H., Shirabe, K., Oda, Y., Maehara, Y., Komune, S., Mori, M., Suzuki, Y., Yamamoto, K., Aburatani, H., Ogawa, S., Miyano, S., & Mimori, K. (2017). Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution. PLoS genetics, 13(5), e1006798. https://doi.org/10.1371/journal.pgen.1006798
Uchi, Ryutaro, et al. "Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution." PLoS genetics vol. 13,5 (2017): e1006798. doi: https://doi.org/10.1371/journal.pgen.1006798
Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K. Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution. PLoS Genet. 2017 May 19;13(5):e1006798. doi: 10.1371/journal.pgen.1006798. eCollection 2017 May. PMID: 28542232; PMCID: PMC5438101.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 114 entries